UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity

Leukemia, 2014-03, Vol.28 (3), p.649-657

2014

Volltextzugriff (PDF)

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study

Annals of oncology, 2009-03, Vol.20 (3), p.520-525

2009

Volltextzugriff (PDF)

Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors

Annals of oncology, 2010-11, Vol.21 (11), p.2262-2266

2010

Volltextzugriff (PDF)

Characterization of ZnO nanoparticle suspension in water: Effectiveness of ultrasonic dispersion

Powder technology, 2009-08, Vol.194 (1), p.75-80

2009

Volltextzugriff (PDF)

Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma

Annals of oncology, 2009-03, Vol.20 (3), p.413-424

2009

Volltextzugriff (PDF)

Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness

Annals of oncology, 2012-09, Vol.23 (9), p.2356-2362

2012

Volltextzugriff (PDF)

A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma

Annals of oncology, 2007-07, Vol.18 (7), p.1216-1223

2007

Volltextzugriff (PDF)

Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma

Annals of oncology, 2008-10, Vol.19 (10), p.1770-1773

2008

Volltextzugriff (PDF)

Toxicity burden score: a novel approach to summarize multiple toxic effects

Annals of oncology, 2012-02, Vol.23 (2), p.537-541

2012

Volltextzugriff (PDF)

Choice of Ontario high schools and student sorting by ability

Applied economics, 2015-10, Vol.47 (49), p.5282-5302

Leonard, P. S. J.

2015

Volltextzugriff (PDF)

Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies

Annals of oncology, 2008-07, Vol.19 (7), p.1327-1330

2008

Volltextzugriff (PDF)

Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib

Leukemia, 2008-09, Vol.22 (9), p.1755-1766

2008

Volltextzugriff (PDF)

Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12

The Journal of experimental medicine, 1995-01, Vol.181 (1), p.381-386

1995

Volltextzugriff (PDF)

A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance)

Annals of oncology, 2017-11, Vol.28 (11), p.2806-2812

2017

Volltextzugriff (PDF)

Four-zone solidification microstructure formed by laser melting of copper thin films

Applied surface science, 2009-10, Vol.256 (1), p.105-111

2009

Volltextzugriff (PDF)

Iron losses under PWM excitation using a dynamic hysteresis model and finite elements

IEEE transactions on magnetics, 2006-04, Vol.42 (4), p.907-910

2006

Volltextzugriff (PDF)

Electron microscopy of geometrically confined copper thin films after rapid lateral solidification

Thin solid films, 2009-05, Vol.517 (13), p.3629-3634

2009

Volltextzugriff (PDF)

Elitek™-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002

Leukemia, 2003-03, Vol.17 (3), p.499-514

2003

Volltextzugriff (PDF)

Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignancies

Oncogene, 2007-05, Vol.26 (25), p.3704-3713

2007

Volltextzugriff (PDF)

Outcomes of contemporary novel agent incorporation in relapsed/refractory PTCL

Hematological oncology, 2023-06, Vol.41 (S2), p.511-512

2023

Volltextzugriff (PDF)

SWOG 2114: A RANDOMIZED PHASE II TRIAL OF CONSOLIDATION THERAPY FOLLOWING CD19 CAR T‐CELL TREATMENT FOR RELAPSED/REFRACTORY LARGE B‐CELL OR GRADE IIIB FOLLICULAR LYMPHOMA

Hematological oncology, 2023-06, Vol.41 (S2), p.839-840

2023

Volltextzugriff (PDF)

Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness

Annals of oncology, 2018-11, Vol.29 (11), p.2271-2271

2018

Volltextzugriff (PDF)

Suppression of dewetting phenomena during excimer laser melting of thin metal films on SiO2

Thin solid films, 2005-09, Vol.488 (1-2), p.306-313

2005

Volltextzugriff (PDF)

A “FUNCTIONAL CURE” MAY BE ACHIEVABLE IN A SUBSET OF PATIENTS WITH FOLLICULAR LYMPHOMA TREATED WITH CHEMOIMMUNOTHERAPY: 15‐YEAR FOLLOW‐UP OF PHASE III SWOG‐S0016

Hematological oncology, 2023-06, Vol.41 (S2), p.116-117

2023

Volltextzugriff (PDF)

PHASE II/III STUDY OF R‐MINICHOP ± ORAL AZACITIDINE IN PARTICIPANTS AGE 75 YEARS OR OLDER WITH DIFFUSE LARGE B CELL AND RELATED LYMPHOMAS

Hematological oncology, 2023-06, Vol.41 (S2), p.848-849

2023

Volltextzugriff (PDF)

1 – 25 von 11.195

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(9.860)
Mit Volltextzugriff
(8.905)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(7.399)
Life Sciences & Biomedicine
(5.514)
Humans
(4.378)
Male
(2.603)
Biological And Medical Sciences
(2.484)
Female
(2.467)
Medical Sciences
(1.904)
Animals
(1.716)
Adult
(1.476)
Middle Aged
(1.408)
Physical Sciences
(1.297)
Aged
(1.067)
Technology
(808)
Fundamental And Applied Biological Sciences. Psychology
(662)
Physics
(662)
Adolescent
(608)
Mice
(595)
Child
(575)
Oncology
(570)
Neurosciences & Neurology
(555)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(5.835)
EZB Electronic Journals Library
(4.693)
IngentaConnect
(4.210)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(3.959)
NUS Single-Journal Subscriptions
(3.368)
Elsevier ScienceDirect Journals Complete
(2.255)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.578)
Wiley-Blackwell Journals
(1.373)
IngentaConnect Journals
(1.290)
Wiley Online Library
(990)
Springer Online Journals
(718)
JSTOR
(698)
Oxford Journals
(527)
Oxford Journals 2020 Medicine
(375)
Nature
(358)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(352)
Taylor & Francis
(351)
Taylor & Francis Journals
(344)
IEEE Xplore
(338)
Taylor & Francis Journals Complete
(308)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study

Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors

Characterization of ZnO nanoparticle suspension in water: Effectiveness of ultrasonic dispersion

Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma

Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness

A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma

Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma

Toxicity burden score: a novel approach to summarize multiple toxic effects

Choice of Ontario high schools and student sorting by ability

Intensive treatment strategies may not provide superior outcomes in mantle cell lymphoma: overall survival exceeding 7 years with standard therapies

Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib

Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12

A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance)

Four-zone solidification microstructure formed by laser melting of copper thin films

Iron losses under PWM excitation using a dynamic hysteresis model and finite elements

Electron microscopy of geometrically confined copper thin films after rapid lateral solidification

Elitek™-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002

Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignancies

Outcomes of contemporary novel agent incorporation in relapsed/refractory PTCL

SWOG 2114: A RANDOMIZED PHASE II TRIAL OF CONSOLIDATION THERAPY FOLLOWING CD19 CAR T‐CELL TREATMENT FOR RELAPSED/REFRACTORY LARGE B‐CELL OR GRADE IIIB FOLLICULAR LYMPHOMA

Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsiveness

Suppression of dewetting phenomena during excimer laser melting of thin metal films on SiO2

A “FUNCTIONAL CURE” MAY BE ACHIEVABLE IN A SUBSET OF PATIENTS WITH FOLLICULAR LYMPHOMA TREATED WITH CHEMOIMMUNOTHERAPY: 15‐YEAR FOLLOW‐UP OF PHASE III SWOG‐S0016

PHASE II/III STUDY OF R‐MINICHOP ± ORAL AZACITIDINE IN PARTICIPANTS AGE 75 YEARS OR OLDER WITH DIFFUSE LARGE B CELL AND RELATED LYMPHOMAS

Suchergebnisse filtern